Search results
White House Launches Initiatives to Bolster New Nuclear Deployments
POWER Magazine via Yahoo Finance· 7 days agoThe White House has unveiled a suite of new measures aimed at slashing risks associated with new...
Is this a Hitler documentary worth watching?
The Forward· 13 hours agoThere is no documentary subject more urgent and more overexposed than Hitler and the Nazis. In six parts, Hitler and the Nazis: Murder on Trial, explores...
Exclusive: Qatar sovereign fund agrees to buy 10% stake in China asset manager, sources say
Reuters· 2 days agoQatar's sovereign wealth fund has agreed to buy a 10% stake in China's second-largest mutual fund...
CrowdStrike shares target raised on strong 1Q results By Investing.com
Investing.com· 16 hours agoOn Wednesday, CrowdStrike Holdings (NASDAQ:CRWD) received a price target increase from Oppenheimer,...
Republicans target FBI, Trump prosecutors post-verdict
The Hill via Yahoo News· 18 hours agoRepublicans are ramping up their efforts to attack the FBI and prosecutors such as Manhattan...
‘All eyes on Rafah’ is the Internet’s most viral AI image. Two artists are claiming credit
MPR News· 2 days agoTwo Malaysians separated by 900 miles are both taking credit for a synthetic image of Gaza that...
Plug Power holds Underperform stock rating amid DOE loan scrutiny By Investing.com
Investing.com· 11 hours agoOn Wednesday, BMO Capital maintained its Underperform rating on Plug Power (NASDAQ:PLUG) with a...
Call for Stories: Local podcast seeks Moab rescue stories for Outdoor Safety Education - The...
The Moab Times-Independent· 1 day agoIn a six-episode series, this podcast will highlight the incredible recreation opportunities in...
‘Why Lawd?’ by NxWorries Review: A Soul Celebration
The Wall Street Journal· 1 day agoSubsonic bass and highly compressed drums on tracks like “FallThru” evoke neo-soul from the turn of the millennium as practiced by D’Angelo and Erykah...
I-Mab and Bristol Myers team up for cancer drug trial By Investing.com
Investing.com· 11 hours agoI-Mab (NASDAQ: IMAB), a biotechnology firm specializing in cancer immunotherapies, has announced a...